Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr286 Inhibitors

Olr286 inhibitors represent a specific class of chemical compounds that interact with the Olr286 receptor, which belongs to the family of olfactory receptors. Olfactory receptors are G-protein-coupled receptors (GPCRs) primarily found in the nasal epithelium and are responsible for detecting and transducing odorant signals into the brain. The Olr286 receptor is one of the numerous olfactory receptors encoded in the genome, each with distinct ligand specificities that contribute to the diversity of odor detection. Inhibitors targeting Olr286 are designed to specifically block or modulate the receptor's ability to bind to its natural ligands, thereby altering the receptor's signaling cascade. The molecular mechanisms of these inhibitors often involve binding to the receptor's active site, preventing the interaction with odorant molecules or causing conformational changes that disrupt the normal function of the receptor.

These inhibitors are crucial tools in understanding the structural and functional dynamics of the Olr286 receptor and related GPCRs. By studying these interactions, researchers can gain insights into the specificity and selectivity of ligand-receptor binding, the structural conformations of the receptor in both active and inactive states, and the subsequent intracellular signaling pathways triggered by receptor activation or inhibition. Additionally, Olr286 inhibitors contribute to the broader field of chemical biology by serving as molecular probes to dissect the complex networks of olfactory signal transduction. These studies can also extend to the exploration of receptor-ligand co-evolution and the evolutionary pressures that shaped the diversification of olfactory receptors across species. Thus, the investigation of Olr286 inhibitors is integral to advancing our understanding of olfactory receptor biology, receptor-ligand interactions, and the general principles of GPCR function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Inhibits phosphodiesterases, leading to increased cAMP, possibly affecting Olr286 signaling.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Phosphodiesterase inhibitor, may enhance cAMP-mediated pathways linked to Olr286.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor, possibly modulating GPCR pathways, indirectly affecting Olr286.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MAPK/ERK inhibitor, could alter pathways interacting with Olr286 signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, might modulate pathways interconnected with Olr286 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, potentially influencing pathways associated with Olr286.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, could affect signaling cascades linked to Olr286.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Selectively inhibits MEK, possibly impacting Olr286-related signaling.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

Calcium chelator, might indirectly influence Olr286 activity via calcium signaling.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

SERCA pump inhibitor, potentially modulating calcium stores affecting Olr286.